ASA Lobbies Senate Bill to Address Anesthetic Shortage
In the midst of a shortage on anesthetic drugs, the American Society of Anesthesiologists is asking the Senate to include specific language in the shortage provisions of the FDA's Safety and Innovation Act.
Specifically, ASA successfully lobbied the Senate Committee on Health, Education, Labor and Pensions to include language in the bill that would require manufacturers to notify the FDA when there is a shortage of a "sterile injectable product" or a drug "used in emergency medical care or during surgery."
Anesthetic and central nervous system drugs now account for 23 percent of drug shortages nationwide.
Related Articles on Anesthesia:Stricter Guidelines Needed for Blood Transfusions, Study Says
Anesthesiologist Who Developed Checklist Protocol Receives ABMS Award
Anesthesiologists Are Top Earners in Pennsylvania
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- House Votes to Repeal the PPACA — for 37th Time
- 6 Statistics on Concierge and Direct Pay Physician Practices
- Best Practices: Documentation and Reporting for Post-Operative Pain Management Procedures in Anesthesia
- 5 Things to Know About Medical Office Visits in 2012
- Medical Facilities Corporation Reports Higher Revenue After Arkansas Surgical Hospital Acquisition